205 related articles for article (PubMed ID: 25052881)
1. Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists.
Rose VJ; Lutnick A; Kral AH
J Psychoactive Drugs; 2014; 46(3):226-32. PubMed ID: 25052881
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
[TBL] [Abstract][Full Text] [Related]
3. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
Pollini RA
J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
[TBL] [Abstract][Full Text] [Related]
4. Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.
Lutnick A; Case P; Kral AH
J Urban Health; 2012 Apr; 89(2):354-64. PubMed ID: 22231488
[TBL] [Abstract][Full Text] [Related]
5. Community pharmacist experiences of providing needle and syringe programmes in Ireland.
McVeigh J; Hearne E; Bates G; Van Hout MC
Res Social Adm Pharm; 2017; 13(4):767-777. PubMed ID: 27568822
[TBL] [Abstract][Full Text] [Related]
6. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
Wright-De Agüero L; Weinstein B; Jones TS; Miles J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
[TBL] [Abstract][Full Text] [Related]
7. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island.
Zaller ND; Yokell MA; Green TC; Gaggin J; Case P
Subst Use Misuse; 2013 Jun; 48(8):590-9. PubMed ID: 23750660
[TBL] [Abstract][Full Text] [Related]
8. Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010.
Lutnick A; Cooper E; Dodson C; Bluthenthal R; Kral AH
J Urban Health; 2013 Apr; 90(2):276-83. PubMed ID: 22718357
[TBL] [Abstract][Full Text] [Related]
9. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention.
Zaller ND; Yokell MA; Apeakorang N; Gaggin J; Case P
J Health Care Poor Underserved; 2012 Aug; 23(3):1310-26. PubMed ID: 24212176
[TBL] [Abstract][Full Text] [Related]
10. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.
Fedorova EV; Skochilov RV; Heimer R; Case P; Beletsky L; Grau LE; Kozlov AP; Shaboltas AV
BMC Public Health; 2013 Mar; 13():183. PubMed ID: 23452390
[TBL] [Abstract][Full Text] [Related]
11. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007.
Cooper EN; Dodson C; Stopka TJ; Riley ED; Garfein RS; Bluthenthal RN
J Urban Health; 2010 Jul; 87(4):543-52. PubMed ID: 20549568
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.
Parry RA; Zule WA; Hurt CB; Evon DM; Rhea SK; Carpenter DM
Harm Reduct J; 2021 Jul; 18(1):70. PubMed ID: 34238306
[TBL] [Abstract][Full Text] [Related]
13. Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users.
Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM
Health Educ Behav; 2014 Aug; 41(4):397-405. PubMed ID: 24722219
[TBL] [Abstract][Full Text] [Related]
14. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
[TBL] [Abstract][Full Text] [Related]
15. Community pharmacist perspectives on HIV/AIDS and interventions for injection drug users in Canada.
Myers T; Cockerill R; Worthington C; Millson M; Rankin J
AIDS Care; 1998 Dec; 10(6):689-700. PubMed ID: 9924524
[TBL] [Abstract][Full Text] [Related]
16. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
Coffin PO; Linas BP; Factor SH; Vlahov D
J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
[TBL] [Abstract][Full Text] [Related]
17. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.
Ghaddar A; Nassar K; Elsoury G
Subst Use Misuse; 2017 Sep; 52(11):1420-1428. PubMed ID: 28430013
[TBL] [Abstract][Full Text] [Related]
18. Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approach.
Ibragimov U; Cooper HL; Haardörfer R; Dunkle KL; Zule WA; Wong FY
Harm Reduct J; 2017 Sep; 14(1):64. PubMed ID: 28915888
[TBL] [Abstract][Full Text] [Related]
19. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
Lurie P; Jones TS; Foley J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
[TBL] [Abstract][Full Text] [Related]
20. Nonprescription syringe sales: Resistant pharmacists' attitudes and practices.
Chiarello E
Drug Alcohol Depend; 2016 Sep; 166():45-50. PubMed ID: 27423213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
